These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21056992)

  • 1. Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin.
    Marcar L; Maclaine NJ; Hupp TR; Meek DW
    Cancer Res; 2010 Dec; 70(24):10362-70. PubMed ID: 21056992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents.
    Monte M; Simonatto M; Peche LY; Bublik DR; Gobessi S; Pierotti MA; Rodolfo M; Schneider C
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11160-5. PubMed ID: 16847267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor SMAR1 downregulates Cytokeratin 8 expression by displacing p53 from its cognate site.
    Pavithra L; Singh S; Sreenath K; Chattopadhyay S
    Int J Biochem Cell Biol; 2009 Apr; 41(4):862-71. PubMed ID: 18822384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
    Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
    Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes.
    Tanaka T; Ohkubo S; Tatsuno I; Prives C
    Cell; 2007 Aug; 130(4):638-50. PubMed ID: 17719542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin immunoprecipitation-on-chip reveals stress-dependent p53 occupancy in primary normal cells but not in established cell lines.
    Shaked H; Shiff I; Kott-Gutkowski M; Siegfried Z; Haupt Y; Simon I
    Cancer Res; 2008 Dec; 68(23):9671-7. PubMed ID: 19047144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation.
    Okoshi R; Ando K; Suenaga Y; Sang M; Kubo N; Kizaki H; Nakagawara A; Ozaki T
    Genes Cells; 2009 Dec; 14(12):1429-40. PubMed ID: 19930465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo.
    Kaeser MD; Iggo RD
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):95-100. PubMed ID: 11756653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of p53-mediated transcriptional responses by mithramycin A.
    Koutsodontis G; Kardassis D
    Oncogene; 2004 Dec; 23(57):9190-200. PubMed ID: 15489892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2.
    Leung KM; Po LS; Tsang FC; Siu WY; Lau A; Ho HT; Poon RY
    Cancer Res; 2002 Sep; 62(17):4890-3. PubMed ID: 12208736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
    Liu X; Yue P; Khuri FR; Sun SY
    Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
    Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
    Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
    Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The melanoma antigen genes--any clues to their functions in normal tissues?
    Ohman Forslund K; Nordqvist K
    Exp Cell Res; 2001 May; 265(2):185-94. PubMed ID: 11302683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LMO3 interacts with p53 and inhibits its transcriptional activity.
    Larsen S; Yokochi T; Isogai E; Nakamura Y; Ozaki T; Nakagawara A
    Biochem Biophys Res Commun; 2010 Feb; 392(3):252-7. PubMed ID: 19995558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus core protein interacts with p53-binding protein, 53BP2/Bbp/ASPP2, and inhibits p53-mediated apoptosis.
    Cao Y; Hamada T; Matsui T; Date T; Iwabuchi K
    Biochem Biophys Res Commun; 2004 Mar; 315(4):788-95. PubMed ID: 14985081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.
    Kim E; Rohaly G; Heinrichs S; Gimnopoulos D; Meissner H; Deppert W
    Oncogene; 1999 Dec; 18(51):7310-8. PubMed ID: 10602486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated Notch1 interacts with p53 to inhibit its phosphorylation and transactivation.
    Kim SB; Chae GW; Lee J; Park J; Tak H; Chung JH; Park TG; Ahn JK; Joe CO
    Cell Death Differ; 2007 May; 14(5):982-91. PubMed ID: 17186020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hNRAGE, a human neurotrophin receptor interacting MAGE homologue, regulates p53 transcriptional activity and inhibits cell proliferation.
    Wen CJ; Xue B; Qin WX; Yu M; Zhang MY; Zhao DH; Gao X; Gu JR; Li CJ
    FEBS Lett; 2004 Apr; 564(1-2):171-6. PubMed ID: 15094062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.